From Miami, Florida, USA:
Knowing what we know now about the safety of Lantus and short term insulins, why do pediatric endocrinologists at children's hospitals still use NPH to treat new type 1 patients? Isn't the evidence overwhelming? Why doesn't a national association of endocrinologists do something about stopping this practice?
Some of us have used Lantus for many years with decreased hypoglycemia overnight and improved glucose control. It is difficult to answer your question without specifics. Lantus (and Levemir) are both very acceptable basal insulins to be used as part of an MDI (multiple daily injections) intensive regimen. NPH can also be used successfully, but needs several overlapping doses and often has more hypoglycemia problems associated with it than Lantus and Levemir.
|Return to the Top of This Page|
Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.